APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vaccine

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

Selected research

Market Structure

Global Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026199 pages

Choose your research edition.

Industry ResearchVaccine Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

The global Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Asia Pacific market for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vaccine include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK and Hulan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Vaccine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaccine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaccine Segment by Company

AstraZeneca

BioNTech

Boehringer-Ingelheim

CCBIO

CSL

CureVac

Elanco

GSK

Hulan Bio

Indian Immunologicals

Merck

Minhai Biotechnology

Mitsubishi Tanabe Pharma

Moderna Therapeutics

Mylan

Plumbline Life Sciences

Sanofi

Translate Bio

Walvax Biotechnology

Wuhan Institute of Biological Products

Zoties

Vaccine Segment by Type

Varicella Vaccine

Influenza Vaccine

Polio Vaccine

Hepatitis A Vaccine

Rabies Vaccine

BCG Vaccine

Hepatitis B

Pertussis, Diphtheria, Tetanus

Pneumococcal

Others

Vaccine Segment by Application

For Adult

For Child

Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vaccine industry.

Chapter 3: Detailed analysis of Vaccine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Varicella Vaccine Table 3. Key Players of Influenza Vaccine Table 4. Key Players of Polio Vaccine Table 3. Key Players of Hepatitis A Vaccine Table 4. Key Players of Rabies Vaccine Table 5. Key Players of BCG Vaccine Table 6. Key Players of Hepatitis B Table 7. Key Players of Pertussis, Diphtheria, Tetanus Table 8. Key Players of Pneumococcal Table 9. Key Players of Others Table 10. Global Vaccine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 11. Key Players of For Adult Table 12. Key Players of For Child Table 13. Global Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Vaccine Market Share by Region (2021-2026) Table 16. Global Vaccine Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Vaccine Market Share by Region (2027-2032) Table 18. Vaccine Industry Trends Table 19. Vaccine Industry Drivers Table 20. Vaccine Industry Opportunities and Challenges Table 21. Vaccine Industry Restraints Table 22. Global Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 23. Global Vaccine Revenue Market Share by Company (2021-2026) Table 24. Global Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 25. Global Vaccine Key Company Head Office and Area Served Table 26. Global Vaccine Company, Product Type & Application Table 27. Global Vaccine Company Establishment Date Table 28. Global Company Market Concentration Ratio (CR5 and HHI) Table 29. Global Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 30. Global Vaccine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 32. Global Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 33. Global Vaccine Revenue Market Share by Type (2021-2026) Table 34. Global Vaccine Revenue Market Share by Type (2027-2032) Table 35. Global Vaccine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 37. Global Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 38. Global Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Vaccine Revenue Market Share by Application (2027-2032) Table 40. AstraZeneca Company Information Table 41. AstraZeneca Business Overview Table 42. AstraZeneca Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. AstraZeneca Vaccine Product Portfolio Table 44. AstraZeneca Recent Development Table 45. BioNTech Company Information Table 46. BioNTech Business Overview Table 47. BioNTech Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BioNTech Vaccine Product Portfolio Table 49. BioNTech Recent Development Table 50. Boehringer-Ingelheim Company Information Table 51. Boehringer-Ingelheim Business Overview Table 52. Boehringer-Ingelheim Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Boehringer-Ingelheim Vaccine Product Portfolio Table 54. Boehringer-Ingelheim Recent Development Table 55. CCBIO Company Information Table 56. CCBIO Business Overview Table 57. CCBIO Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. CCBIO Vaccine Product Portfolio Table 59. CCBIO Recent Development Table 60. CSL Company Information Table 61. CSL Business Overview Table 62. CSL Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. CSL Vaccine Product Portfolio Table 64. CSL Recent Development Table 65. CureVac Company Information Table 66. CureVac Business Overview Table 67. CureVac Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. CureVac Vaccine Product Portfolio Table 69. CureVac Recent Development Table 70. Elanco Company Information Table 71. Elanco Business Overview Table 72. Elanco Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Elanco Vaccine Product Portfolio Table 74. Elanco Recent Development Table 75. GSK Company Information Table 76. GSK Business Overview Table 77. GSK Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. GSK Vaccine Product Portfolio Table 79. GSK Recent Development Table 80. Hulan Bio Company Information Table 81. Hulan Bio Business Overview Table 82. Hulan Bio Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Hulan Bio Vaccine Product Portfolio Table 84. Hulan Bio Recent Development Table 85. Indian Immunologicals Company Information Table 86. Indian Immunologicals Business Overview Table 87. Indian Immunologicals Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Indian Immunologicals Vaccine Product Portfolio Table 89. Indian Immunologicals Recent Development Table 90. Merck Company Information Table 91. Merck Business Overview Table 92. Merck Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Merck Vaccine Product Portfolio Table 94. Merck Recent Development Table 95. Minhai Biotechnology Company Information Table 96. Minhai Biotechnology Business Overview Table 97. Minhai Biotechnology Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Minhai Biotechnology Vaccine Product Portfolio Table 99. Minhai Biotechnology Recent Development Table 100. Mitsubishi Tanabe Pharma Company Information Table 101. Mitsubishi Tanabe Pharma Business Overview Table 102. Mitsubishi Tanabe Pharma Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Mitsubishi Tanabe Pharma Vaccine Product Portfolio Table 104. Mitsubishi Tanabe Pharma Recent Development Table 105. Moderna Therapeutics Company Information Table 106. Moderna Therapeutics Business Overview Table 107. Moderna Therapeutics Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Moderna Therapeutics Vaccine Product Portfolio Table 109. Moderna Therapeutics Recent Development Table 110. Mylan Company Information Table 111. Mylan Business Overview Table 112. Mylan Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Mylan Vaccine Product Portfolio Table 114. Mylan Recent Development Table 115. Plumbline Life Sciences Company Information Table 116. Plumbline Life Sciences Business Overview Table 117. Plumbline Life Sciences Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Plumbline Life Sciences Vaccine Product Portfolio Table 119. Plumbline Life Sciences Recent Development Table 120. Sanofi Company Information Table 121. Sanofi Business Overview Table 122. Sanofi Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Sanofi Vaccine Product Portfolio Table 124. Sanofi Recent Development Table 125. Translate Bio Company Information Table 126. Translate Bio Business Overview Table 127. Translate Bio Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Translate Bio Vaccine Product Portfolio Table 129. Translate Bio Recent Development Table 130. Walvax Biotechnology Company Information Table 131. Walvax Biotechnology Business Overview Table 132. Walvax Biotechnology Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Walvax Biotechnology Vaccine Product Portfolio Table 134. Walvax Biotechnology Recent Development Table 135. Wuhan Institute of Biological Products Company Information Table 136. Wuhan Institute of Biological Products Business Overview Table 137. Wuhan Institute of Biological Products Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. Wuhan Institute of Biological Products Vaccine Product Portfolio Table 139. Wuhan Institute of Biological Products Recent Development Table 140. Zoties Company Information Table 141. Zoties Business Overview Table 142. Zoties Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. Zoties Vaccine Product Portfolio Table 144. Zoties Recent Development Table 145. North America Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 146. North America Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 147. North America Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 148. North America Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 149. North America Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America Vaccine Market Size by Country (2021-2026) Table 151. North America Vaccine Market Size by Country (2027-2032) Table 152. Europe Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 153. Europe Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 154. Europe Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 155. Europe Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 156. Europe Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Vaccine Market Size by Country (2021-2026) Table 158. Europe Vaccine Market Size by Country (2027-2032) Table 159. China Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 160. China Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 161. China Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 162. China Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 163. Asia Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 164. Asia Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 165. Asia Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 166. Asia Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 167. Asia Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Asia Vaccine Market Size by Country (2021-2026) Table 169. Asia Vaccine Market Size by Country (2027-2032) Table 170. South America, Middle East & Africa Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 171. South America, Middle East & Africa Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 172. South America, Middle East & Africa Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 173. South America, Middle East & Africa Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 174. South America, Middle East & Africa Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. South America, Middle East & Africa Vaccine Market Size by Country (2021-2026) Table 176. South America, Middle East & Africa Vaccine Market Size by Country (2027-2032) Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Vaccine Product Image Figure 2. Global Vaccine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Vaccine Market Share by Type: 2025 VS 2032 Figure 4. Varicella Vaccine Image Figure 5. Influenza Vaccine Image Figure 6. Polio Vaccine Image Figure 7. Hepatitis A Vaccine Image Figure 8. Rabies Vaccine Image Figure 9. BCG Vaccine Image Figure 10. Hepatitis B Image Figure 11. Pertussis, Diphtheria, Tetanus Image Figure 12. Pneumococcal Image Figure 13. Others Image Figure 14. Global Vaccine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Vaccine Market Share by Application: 2025 VS 2032 Figure 16. For Adult Image Figure 17. For Child Image Figure 18. Global Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Vaccine Market Size (2021-2032) & (US$ Million) Figure 20. Global Vaccine Market Share by Region: 2025 VS 2032 Figure 21. Years Considered Figure 22. Global Vaccine Market Share by Players in 2025 Figure 23. Global Top 5 and 10 Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Vaccine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Vaccine Revenue Market Share by Type (2021-2032) Figure 27. Global Vaccine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Vaccine Revenue Market Share by Application (2021-2032) Figure 29. North America Vaccine Market Size (2021-2032) & (US$ Million) Figure 30. North America Vaccine Market Share by Type (2021-2032) Figure 31. North America Vaccine Market Share by Application (2021-2032) Figure 32. North America Vaccine Market Share by Country (2021-2032) Figure 33. United States Vaccine Market Size (2021-2032) & (US$ Million) Figure 34. Canada Vaccine Market Size (2021-2032) & (US$ Million) Figure 35. Mexico Vaccine Market Size (2021-2032) & (US$ Million) Figure 36. Europe Vaccine Market Size (2021-2032) & (US$ Million) Figure 37. Europe Vaccine Market Share by Type (2021-2032) Figure 38. Europe Vaccine Market Share by Application (2021-2032) Figure 39. Europe Vaccine Market Share by Country (2021-2032) Figure 40. Germany Vaccine Market Size (2021-2032) & (US$ Million) Figure 41. France Vaccine Market Size (2021-2032) & (US$ Million) Figure 42. U.K. Vaccine Market Size (2021-2032) & (US$ Million) Figure 43. Italy Vaccine Market Size (2021-2032) & (US$ Million) Figure 44. Russia Vaccine Market Size (2021-2032) & (US$ Million) Figure 45. Nordic Countries Vaccine Market Size (2021-2032) & (US$ Million) Figure 46. China Vaccine Market Size (2021-2032) & (US$ Million) Figure 47. China Vaccine Market Share by Type (2021-2032) Figure 48. China Vaccine Market Share by Application (2021-2032) Figure 49. Asia Vaccine Market Size (2021-2032) & (US$ Million) Figure 50. Asia Vaccine Market Share by Type (2021-2032) Figure 51. Asia Vaccine Market Share by Application (2021-2032) Figure 52. Asia Vaccine Market Share by Country (2021-2032) Figure 53. Japan Vaccine Market Size (2021-2032) & (US$ Million) Figure 54. South Korea Vaccine Market Size (2021-2032) & (US$ Million) Figure 55. Taiwan Vaccine Market Size (2021-2032) & (US$ Million) Figure 56. Southeast Asia Vaccine Market Size (2021-2032) & (US$ Million) Figure 57. India Vaccine Market Size (2021-2032) & (US$ Million) Figure 58. Australia Vaccine Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Vaccine Market Size (2021-2032) & (US$ Million) Figure 60. South America, Middle East & Africa Vaccine Market Share by Type (2021-2032) Figure 61. South America, Middle East & Africa Vaccine Market Share by Application (2021-2032) Figure 62. South America, Middle East & Africa Vaccine Market Share by Country (2021-2032) Figure 63. Brazil Vaccine Market Size (2021-2032) & (US$ Million) Figure 64. South Africa Vaccine Market Size (2021-2032) & (US$ Million) Figure 65. Saudi Arabia Vaccine Market Size (2021-2032) & (US$ Million) Figure 66. Turkey Vaccine Market Size (2021-2032) & (US$ Million) Figure 67. Argentina Vaccine Market Size (2021-2032) & (US$ Million) Figure 68. UAE Vaccine Market Size (2021-2032) & (US$ Million) Figure 69. Egypt Vaccine Market Size (2021-2032) & (US$ Million) Figure 70. Chile Vaccine Market Size (2021-2032) & (US$ Million) Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Varicella Vaccine
  • Influenza Vaccine
  • Polio Vaccine
  • Hepatitis A Vaccine
  • Rabies Vaccine
  • BCG Vaccine
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Others
Applications
  • For Adult
  • For Child
Companies covered
  • AstraZeneca
  • BioNTech
  • Boehringer-Ingelheim
  • CCBIO
  • CSL
  • CureVac
  • Elanco
  • GSK
  • Hulan Bio
  • Indian Immunologicals
  • Merck
  • Minhai Biotechnology
  • Mitsubishi Tanabe Pharma
  • Moderna Therapeutics
  • Mylan
  • Plumbline Life Sciences
  • Sanofi
  • Translate Bio
  • Walvax Biotechnology
  • Wuhan Institute of Biological Products
  • Zoties

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Vaccine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Varicella Vaccine
  5. 1.2.3 Influenza Vaccine
  6. 1.2.4 Polio Vaccine
  7. 1.2.5 Hepatitis A Vaccine
  8. 1.2.6 Rabies Vaccine
  9. 1.2.7 BCG Vaccine
  10. 1.2.8 Hepatitis B
  11. 1.2.9 Pertussis, Diphtheria, Tetanus
  12. 1.2.10 Pneumococcal
  13. 1.2.11 Others
  14. 1.3 Market Analysis by Application
  15. 1.3.1 Global Vaccine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  16. 1.3.2 For Adult
  17. 1.3.3 For Child
  18. 1.4 Global Market Growth Prospects
  19. 1.5 Global Vaccine Growth Trends by Region
  20. 1.5.1 Global Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  21. 1.5.2 Vaccine Market Size by Region (2021-2026)
  22. 1.5.3 Vaccine Market Size by Region (2027-2032)
  23. 1.6 Assumptions and Limitations
  24. 1.7 Study Goals and Objectives
  25. 1.8 Years Considered
2 Global Vaccine Market Dynamics
  1. 2.1 Vaccine Industry Trends
  2. 2.2 Vaccine Industry Drivers
  3. 2.3 Vaccine Industry Opportunities and Challenges
  4. 2.4 Vaccine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Vaccine Revenue by Company (2021-2026)
  2. 3.2 Global Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Vaccine Key Company Head office and Area Served
  4. 3.4 Global Vaccine Company, Product Type & Application
  5. 3.5 Global Vaccine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Vaccine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Vaccine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Vaccine Tier 1, Tier 2, and Tier 3
4 Vaccine Market by Type
  1. 4.1 Global Vaccine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Vaccine Market Size by Type (2021-2032)
  3. 4.3 Global Vaccine Market Size Share by Type (2021-2032)
5 Vaccine Market by Application
  1. 5.1 Global Vaccine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Vaccine Market Size by Application (2021-2032)
  3. 5.3 Global Vaccine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AstraZeneca Vaccine Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 BioNTech
  8. 6.2.1 BioNTech Company Information
  9. 6.2.2 BioNTech Business Overview
  10. 6.2.3 BioNTech Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BioNTech Vaccine Product Portfolio
  12. 6.2.5 BioNTech Recent Developments
  13. 6.3 Boehringer-Ingelheim
  14. 6.3.1 Boehringer-Ingelheim Company Information
  15. 6.3.2 Boehringer-Ingelheim Business Overview
  16. 6.3.3 Boehringer-Ingelheim Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Boehringer-Ingelheim Vaccine Product Portfolio
  18. 6.3.5 Boehringer-Ingelheim Recent Developments
  19. 6.4 CCBIO
  20. 6.4.1 CCBIO Company Information
  21. 6.4.2 CCBIO Business Overview
  22. 6.4.3 CCBIO Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 CCBIO Vaccine Product Portfolio
  24. 6.4.5 CCBIO Recent Developments
  25. 6.5 CSL
  26. 6.5.1 CSL Company Information
  27. 6.5.2 CSL Business Overview
  28. 6.5.3 CSL Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 CSL Vaccine Product Portfolio
  30. 6.5.5 CSL Recent Developments
  31. 6.6 CureVac
  32. 6.6.1 CureVac Company Information
  33. 6.6.2 CureVac Business Overview
  34. 6.6.3 CureVac Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 CureVac Vaccine Product Portfolio
  36. 6.6.5 CureVac Recent Developments
  37. 6.7 Elanco
  38. 6.7.1 Elanco Company Information
  39. 6.7.2 Elanco Business Overview
  40. 6.7.3 Elanco Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Elanco Vaccine Product Portfolio
  42. 6.7.5 Elanco Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GSK Vaccine Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Hulan Bio
  50. 6.9.1 Hulan Bio Company Information
  51. 6.9.2 Hulan Bio Business Overview
  52. 6.9.3 Hulan Bio Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Hulan Bio Vaccine Product Portfolio
  54. 6.9.5 Hulan Bio Recent Developments
  55. 6.10 Indian Immunologicals
  56. 6.10.1 Indian Immunologicals Company Information
  57. 6.10.2 Indian Immunologicals Business Overview
  58. 6.10.3 Indian Immunologicals Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Indian Immunologicals Vaccine Product Portfolio
  60. 6.10.5 Indian Immunologicals Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Merck Vaccine Product Portfolio
  66. 6.11.5 Merck Recent Developments
  67. 6.12 Minhai Biotechnology
  68. 6.12.1 Minhai Biotechnology Company Information
  69. 6.12.2 Minhai Biotechnology Business Overview
  70. 6.12.3 Minhai Biotechnology Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Minhai Biotechnology Vaccine Product Portfolio
  72. 6.12.5 Minhai Biotechnology Recent Developments
  73. 6.13 Mitsubishi Tanabe Pharma
  74. 6.13.1 Mitsubishi Tanabe Pharma Company Information
  75. 6.13.2 Mitsubishi Tanabe Pharma Business Overview
  76. 6.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Mitsubishi Tanabe Pharma Vaccine Product Portfolio
  78. 6.13.5 Mitsubishi Tanabe Pharma Recent Developments
  79. 6.14 Moderna Therapeutics
  80. 6.14.1 Moderna Therapeutics Company Information
  81. 6.14.2 Moderna Therapeutics Business Overview
  82. 6.14.3 Moderna Therapeutics Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Moderna Therapeutics Vaccine Product Portfolio
  84. 6.14.5 Moderna Therapeutics Recent Developments
  85. 6.15 Mylan
  86. 6.15.1 Mylan Company Information
  87. 6.15.2 Mylan Business Overview
  88. 6.15.3 Mylan Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Mylan Vaccine Product Portfolio
  90. 6.15.5 Mylan Recent Developments
  91. 6.16 Plumbline Life Sciences
  92. 6.16.1 Plumbline Life Sciences Company Information
  93. 6.16.2 Plumbline Life Sciences Business Overview
  94. 6.16.3 Plumbline Life Sciences Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Plumbline Life Sciences Vaccine Product Portfolio
  96. 6.16.5 Plumbline Life Sciences Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Sanofi Vaccine Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Translate Bio
  104. 6.18.1 Translate Bio Company Information
  105. 6.18.2 Translate Bio Business Overview
  106. 6.18.3 Translate Bio Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Translate Bio Vaccine Product Portfolio
  108. 6.18.5 Translate Bio Recent Developments
  109. 6.19 Walvax Biotechnology
  110. 6.19.1 Walvax Biotechnology Company Information
  111. 6.19.2 Walvax Biotechnology Business Overview
  112. 6.19.3 Walvax Biotechnology Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Walvax Biotechnology Vaccine Product Portfolio
  114. 6.19.5 Walvax Biotechnology Recent Developments
  115. 6.20 Wuhan Institute of Biological Products
  116. 6.20.1 Wuhan Institute of Biological Products Company Information
  117. 6.20.2 Wuhan Institute of Biological Products Business Overview
  118. 6.20.3 Wuhan Institute of Biological Products Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Wuhan Institute of Biological Products Vaccine Product Portfolio
  120. 6.20.5 Wuhan Institute of Biological Products Recent Developments
  121. 6.21 Zoties
  122. 6.21.1 Zoties Company Information
  123. 6.21.2 Zoties Business Overview
  124. 6.21.3 Zoties Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Zoties Vaccine Product Portfolio
  126. 6.21.5 Zoties Recent Developments
7 North America
  1. 7.1 North America Vaccine Market Size (2021-2032)
  2. 7.2 North America Vaccine Market Size by Type
  3. 7.2.1 North America Vaccine Market Size by Type (2021-2026)
  4. 7.2.2 North America Vaccine Market Size by Type (2027-2032)
  5. 7.2.3 North America Vaccine Market Share by Type (2021-2032)
  6. 7.3 North America Vaccine Market Size by Application
  7. 7.3.1 North America Vaccine Market Size by Application (2021-2026)
  8. 7.3.2 North America Vaccine Market Size by Application (2027-2032)
  9. 7.3.3 North America Vaccine Market Share by Application (2021-2032)
  10. 7.4 North America Vaccine Market Size by Country
  11. 7.4.1 North America Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Vaccine Market Size by Country (2021-2026)
  13. 7.4.3 North America Vaccine Market Size by Country (2027-2032)
  14. 7.4.4 North America Vaccine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Vaccine Market Size (2021-2032)
  2. 8.2 Europe Vaccine Market Size by Type
  3. 8.2.1 Europe Vaccine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Vaccine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Vaccine Market Share by Type (2021-2032)
  6. 8.3 Europe Vaccine Market Size by Application
  7. 8.3.1 Europe Vaccine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Vaccine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Vaccine Market Share by Application (2021-2032)
  10. 8.4 Europe Vaccine Market Size by Country
  11. 8.4.1 Europe Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Vaccine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Vaccine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Vaccine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Vaccine Market Size (2021-2032)
  2. 9.2 China Vaccine Market Size by Type
  3. 9.2.1 China Vaccine Market Size by Type (2021-2026)
  4. 9.2.2 China Vaccine Market Size by Type (2027-2032)
  5. 9.2.3 China Vaccine Market Share by Type (2021-2032)
  6. 9.3 China Vaccine Market Size by Application
  7. 9.3.1 China Vaccine Market Size by Application (2021-2026)
  8. 9.3.2 China Vaccine Market Size by Application (2027-2032)
  9. 9.3.3 China Vaccine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Vaccine Market Size (2021-2032)
  2. 10.2 Asia Vaccine Market Size by Type
  3. 10.2.1 Asia Vaccine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Vaccine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Vaccine Market Share by Type (2021-2032)
  6. 10.3 Asia Vaccine Market Size by Application
  7. 10.3.1 Asia Vaccine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Vaccine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Vaccine Market Share by Application (2021-2032)
  10. 10.4 Asia Vaccine Market Size by Country
  11. 10.4.1 Asia Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Vaccine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Vaccine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Vaccine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Vaccine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Vaccine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Vaccine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Vaccine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Vaccine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Vaccine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Vaccine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Vaccine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Vaccine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Vaccine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Vaccine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Vaccine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Vaccine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst